Axa SA (NASDAQ:AXAHY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday. The brokerage currently has a $33.00 price target on the financial services provider’s stock. Zacks Investment Research‘s price target points to a potential upside of 12.28% from the stock’s previous close.

According to Zacks, “The AXA Group is an international group of insurance and related financial services companies. AXA’s insurance operations are diverse geographically, with activities in 50 countries, principally Western Europe, North America and the Asia/Pacific area. In the United States, AXA is represented through its 60% holding in The Equitable companies and its subsidiaries, Equitable Life, Alliance Capital management and Donaldson, Lufkin & Jenrette. “

Separately, ValuEngine raised shares of Axa SA from a “buy” rating to a “strong-buy” rating in a research note on Thursday, July 27th.

Shares of Axa SA (AXAHY) traded down 0.27% during mid-day trading on Wednesday, reaching $29.39. The company’s stock had a trading volume of 81,635 shares. Axa SA has a 12 month low of $20.40 and a 12 month high of $30.26.

COPYRIGHT VIOLATION WARNING: “Axa SA (AXAHY) Upgraded to Buy by Zacks Investment Research” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at

Axa SA Company Profile

AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.

Receive News & Stock Ratings for Axa SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axa SA and related stocks with our FREE daily email newsletter.